CLINICAL_TRIALS
trial_result
· 2012-04-12
Clinical Trial Update: A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults [Phase 1]
Summary
Pfizer's Phase 1 study reports on the safety, tolerability, and pharmacokinetics of single doses of PF-05180999 in healthy adults; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED